Breast cancer

ALCINA-2

Analysis of Circulating Tumor Markers in Blood
  • Open at Paris since : 22/04/2022
  • Open at Saint-Cloud since : 25/04/2022
  • Target : Adult
  • Phase : Clinical trial

Trial description

The circulating tumoral biomarkers in the blood are the object of numerous researches for several decades. The potential clinical interests of these circulating biomarkers are diagnostic, prognostic, predictive of the efficiency of targeted therapies (according to the mutational profile of the cancer), and could allow the study of the mechanisms of resistance under process. In the multiplicity of these blood potential biomarkers joins a permanent evolution of the technological means used to detect them/to quantify, as well as to estimate their clinical utility.
Url of the trial

Main investigator

FRANCOIS-CLEMENT BIDARD

Professeur - Médecin

Contact